£0.75
0.86% yesterday
London, Dec 24, 01:35 pm CET
ISIN
GB00BL6NGV24
Symbol
DOCS

Dr Martens Target price 2025 - Analyst rating & recommendation

Dr Martens Classifications & Recommendation:

Buy
60%
Hold
40%

Dr Martens Price Target

Target Price £1.02
Price £0.75
Potential
Number of Estimates 8
8 Analysts have issued a price target Dr Martens 2026 . The average Dr Martens target price is £1.02. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 6 Analysts recommend Dr Martens to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Dr Martens stock has an average upside potential 2026 of . Most analysts recommend the Dr Martens stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Revenue Million £ 787.60 810.02
10.20% 2.85%
EBITDA Margin 18.08% 19.33%
20.19% 6.91%
Net Margin 0.57% 4.97%
92.76% 769.86%

8 Analysts have issued a sales forecast Dr Martens 2026 . The average Dr Martens sales estimate is

£810m
Unlock
. This is
3.19% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
£856m 9.01%
Unlock
, the lowest is
£772m 1.63%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 £788m 10.20%
2026
£810m 2.85%
Unlock
2027
£855m 5.59%
Unlock
2028
£897m 4.89%
Unlock
2029
£935m 4.26%
Unlock
2030
£979m 4.63%
Unlock
2031
£1.0b 4.64%
Unlock
2032
£1.1b 4.59%
Unlock

8 Analysts have issued an Dr Martens EBITDA forecast 2026. The average Dr Martens EBITDA estimate is

£157m
Unlock
. This is
10.67% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
£168m 4.16%
Unlock
, the lowest is
£147m 15.86%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 £142m 28.33%
2026
£157m 9.97%
Unlock
2027
£178m 13.61%
Unlock
2028
£195m 9.73%
Unlock

EBITDA Margin

2025 18.08% 20.19%
2026
19.33% 6.91%
Unlock
2027
20.80% 7.60%
Unlock
2028
21.76% 4.62%
Unlock

8 Dr Martens Analysts have issued a net profit forecast 2026. The average Dr Martens net profit estimate is

£40.3m
Unlock
. This is
163.14% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
£43.9m 187.19%
Unlock
, the lowest is
£37.9m 147.58%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 £4.5m 93.50%
2026
£40.3m 794.67%
Unlock
2027
£55.1m 36.81%
Unlock
2028
£66.7m 21.17%
Unlock

Net Margin

2025 0.57% 92.76%
2026
4.97% 769.86%
Unlock
2027
6.44% 29.58%
Unlock
2028
7.44% 15.53%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032

Create a premium account to unlock analyst estimates. Learn more

Mar '25 2026
Estimates
Earnings Per Share £ 0.00 0.04
100.00%
P/E 18.06
EV/Sales 1.27

8 Analysts have issued a Dr Martens forecast for earnings per share. The average Dr Martens EPS is

£0.04
Unlock
. This is
100.00% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
£0.05 150.00%
Unlock
, the lowest is
£0.04 100.00%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 £0.00 100.00%
2027
£0.06 50.00%
Unlock
2028
£0.07 16.67%
Unlock

P/E ratio

Current 37.63 55.56%
2026
18.06 52.00%
Unlock
2027
13.20 26.91%
Unlock
2028
10.90 17.42%
Unlock

Based on analysts' sales estimates for 2026, the Dr Martens stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.32 1.54%
2026
1.27 3.42%
Unlock
2027
1.21 5.29%
Unlock
2028
1.15 4.65%
Unlock
2029
1.10 4.09%
Unlock
2030
1.06 4.43%
Unlock
2031
1.01 4.43%
Unlock
2032
0.96 4.39%
Unlock

P/S ratio

Current 0.93 6.89%
2026
0.91 3.08%
Unlock
2027
0.86 5.29%
Unlock
2028
0.82 4.66%
Unlock
2029
0.78 4.09%
Unlock
2030
0.75 4.42%
Unlock
2031
0.72 4.43%
Unlock
2032
0.68 4.40%
Unlock

Current Dr Martens Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Berenberg Bank
Locked
Locked
Locked Nov 27 2025
Peel Hunt Limited
Locked
Locked
Locked Nov 20 2025
Deutsche
Locked
Locked
Locked Jul 11 2025
RBC Capital Markets
Locked
Locked
Locked May 19 2025
Analyst Rating Date
Locked
Berenberg Bank:
Locked
Locked
Nov 27 2025
Locked
Peel Hunt Limited:
Locked
Locked
Nov 20 2025
Locked
Deutsche:
Locked
Locked
Jul 11 2025
Locked
RBC Capital Markets:
Locked
Locked
May 19 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today